Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Bioavailable toxicity identification evaluation

Fig. 6 Different steps to be followed in the new concept of a bioavailable toxicity identification evaluation (BTIE) method... Fig. 6 Different steps to be followed in the new concept of a bioavailable toxicity identification evaluation (BTIE) method...
Drug Discovery Today 7 25-27 Li AP (2004) In vitro approaches to evaluate ADMET drug properties. Curr Top Med Chem 4 701-706 Li W, Escarpe PA, Eisenberg EJ et al. (1998) Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrobial Agents and Chemotherapy 42 647-653 Los LE, Welsh DA, Herold EG et al. (1996) Gender differences in toxicokinetics, liver metabolism, and plasma esterase activity observations from a chronic (27-week) toxicity study of enalapril/diltiazem combinations in rats. Drug Metab Dispos 24 28-33... [Pg.499]

See other pages where Bioavailable toxicity identification evaluation is mentioned: [Pg.22]    [Pg.45]    [Pg.22]    [Pg.45]    [Pg.71]    [Pg.169]    [Pg.95]    [Pg.105]    [Pg.499]    [Pg.592]    [Pg.220]    [Pg.458]   
See also in sourсe #XX -- [ Pg.45 ]



SEARCH



Bioavailable toxicity identification

Toxicity, evaluation

© 2024 chempedia.info